Global HIV Vaccine Market & Clinical Trial Outlook 2022

The “Global HIV Vaccine Market & Clinical Trial Outlook 2022” report analyzes various multiple clinical and non-clinical aspects related to development of HIV vaccine worldwide. Currently there is no particular vaccine available for the treatment of HIV across the globe. There are multiple vaccines in clinical trials for the treatment and the prevention of HIV. …

Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014 – 2025

The global immunomodulators market is expected to reach USD 233.7 billion by 2025, according to this new study. The market is anticipated to be predominantly driven by high R&D investments employed by the prominent companies, resulting into the large-scale production of new and therapeutically advanced drugs. This is believed to widen the influx of drugs …

Global HIV Therapeutic & Preventive Vaccines Market – Segmented by Type and Geography 2017 – 2022

HIV/AIDS has become one of the leading infectious diseases which is taking a huge death toll across the globe, surpassing malaria and TB. There were about 35.3 million people currently living with HIV. In recent years there have been significant developments achieved in terms of prevention and treatment of HIV/AIDS. The HIV vaccines market is …

Global Hepatitis B Vaccines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

Hepatitis B Vaccines Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 the global hepatitis B vaccines market was valued at US$ 1.39 Bn in 2016, and is expected to reach US$ 1.89 Bn by 2025, expanding at a CAGR of 3.5% from 2017 to 2025. Market Insights Hepatitis B is life threatening …

Antiviral Therapeutics – Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical classification of viral diseases according to their commercial importance. Various antiviral approaches are described including pharmaceuticals and molecular biological therapies such as gene therapy and RNA interference (RNAi) as well …

Therapeutic Vaccine Market: By Vaccine Type (Addiction, Neurological, Infectious, Autoimmune); By Technology (Autologous, Allogenic) & By Region (Europe, Asia-Pacific)-Forecast (2016-2021)

A vaccine is a biological medical product designed to stimulate antibodies inside the human body against any antibody attack. Vaccine helps in providing immunity against various infectious diseases. Vaccines can be broadly classified as prophylactic and therapeutic. Therapeutic vaccines also known as treatment vaccines spur the immune system to attack targeted tissue and is a …

Asia Pacific Anti-Viral drugs Market Outlook – Market size, Segmentation, Market Share and Competitive Landscape (2016 – 2021)

In the year 2015, the Asia Pacific (APAC) Anti-Viral drugs market was valued at USD XX Million. It is expected to increase to an estimated market value of USD XX Million while growing at a CAGR of XX.X% during the forecast period. Anti-Viral drugs are the drugs used to treat viral infections which can range …

Italy Anti-Viral drugs Market Outlook – Market size, Segmentation, Market Share and Competitive Landscape (2016 – 2021)

In the year 2015, the Italy Anti-Viral drugs market was valued at USD XX Million. It is expected to increase to an estimated market value of USD XX Million while growing at a CAGR of XX.X% during the forecast period. Anti-Viral drugs are the drugs used to treat viral infections which can range from infections …